Table of Contents

2019-2024 Global Rare Disease Diagnostics Market Report (Status and Outlook)

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Rare Disease Diagnostics Market Size 2014-2024
  • 2.1.2 Rare Disease Diagnostics Market Size CAGR by Region
• 2.2 Rare Disease Diagnostics Segment by Type
  • 2.2.1 Hematology
  • 2.2.2 Oncology
• 2.3 Rare Disease Diagnostics Market Size by Type
  • 2.3.1 Global Rare Disease Diagnostics Market Size Market Share by Type (2014-2019)
  • 2.3.2 Global Rare Disease Diagnostics Market Size Growth Rate by Type (2014-2019)
• 2.4 Rare Disease Diagnostics Segment by Application
  • 2.4.1 Hospital Laboratories
  • 2.4.2 Diagnostic Laboratories
  • 2.4.3 Genetic Testing Laboratories
  • 2.4.4 Cancer Research Laboratories
  • 2.4.5 Others
• 2.5 Rare Disease Diagnostics Market Size by Application
  • 2.5.1 Global Rare Disease Diagnostics Market Size Market Share by Application (2014-2019)
  • 2.5.2 Global Rare Disease Diagnostics Market Size Growth Rate by Application (2014-2019)

3 Global Rare Disease Diagnostics by Players

• 3.1 Global Rare Disease Diagnostics Market Size Market Share by Players
  • 3.1.1 Global Rare Disease Diagnostics Market Size by Players (2017-2019)
  • 3.1.2 Global Rare Disease Diagnostics Market Size Market Share by Players (2017-2019)
• 3.2 Global Rare Disease Diagnostics Key Players Head office and Products Offered
• 3.3 Market Concentration Rate Analysis
  • 3.3.1 Competition Landscape Analysis
  • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.4 New Products and Potential Entrants
• 3.5 Mergers & Acquisitions, Expansion

4 Rare Disease Diagnostics by Regions

• 4.1 Rare Disease Diagnostics Market Size by Regions
• 4.2 Americas Rare Disease Diagnostics Market Size Growth
• 4.3 APAC Rare Disease Diagnostics Market Size Growth
• 4.4 Europe Rare Disease Diagnostics Market Size Growth
• 4.5 Middle East & Africa Rare Disease Diagnostics Market Size Growth

5 Americas

• 5.1 Americas Rare Disease Diagnostics Market Size by Countries
• 5.2 Americas Rare Disease Diagnostics Market Size by Type
• 5.3 Americas Rare Disease Diagnostics Market Size by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Rare Disease Diagnostics Market Size by Countries
• 6.2 APAC Rare Disease Diagnostics Market Size by Type
• 6.3 APAC Rare Disease Diagnostics Market Size by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Rare Disease Diagnostics by Countries
• 7.2 Europe Rare Disease Diagnostics Market Size by Type
• 7.3 Europe Rare Disease Diagnostics Market Size by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Rare Disease Diagnostics by Countries
• 8.2 Middle East & Africa Rare Disease Diagnostics Market Size by Type
• 8.3 Middle East & Africa Rare Disease Diagnostics Market Size by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Global Rare Disease Diagnostics Market Forecast

• 10.1 Global Rare Disease Diagnostics Market Size Forecast (2019-2024)
• 10.2 Global Rare Disease Diagnostics Forecast by Regions
  • 10.2.1 Global Rare Disease Diagnostics Forecast by Regions (2019-2024)
  • 10.2.2 Americas Market Forecast
  • 10.2.3 APAC Market Forecast
  • 10.2.4 Europe Market Forecast
  • 10.2.5 Middle East & Africa Market Forecast
• 10.3 Americas Forecast by Countries
  • 10.3.1 United States Market Forecast
  • 10.3.2 Canada Market Forecast
  • 10.3.3 Mexico Market Forecast
  • 10.3.4 Brazil Market Forecast
• 10.4 APAC Forecast by Countries
  • 10.4.1 China Market Forecast
  • 10.4.2 Japan Market Forecast
  • 10.4.3 Korea Market Forecast
  • 10.4.4 Southeast Asia Market Forecast
  • 10.4.5 India Market Forecast
  • 10.4.6 Australia Market Forecast
• 10.5 Europe Forecast by Countries
  • 10.5.1 Germany Market Forecast
  • 10.5.2 France Market Forecast
  • 10.5.3 UK Market Forecast
  • 10.5.4 Italy Market Forecast
  • 10.5.5 Russia Market Forecast
  • 10.5.6 Spain Market Forecast
• 10.6 Middle East & Africa Forecast by Countries
  • 10.6.1 Egypt Market Forecast
  • 10.6.2 South Africa Market Forecast
  • 10.6.3 Israel Market Forecast
  • 10.6.4 Turkey Market Forecast
  • 10.6.5 GCC Countries Market Forecast
• 10.7 Global Rare Disease Diagnostics Forecast by Type
• 10.8 Global Rare Disease Diagnostics Forecast by Application

11 Key Players Analysis

• 11.1 Retrophin
  • 11.1.1 Company Details
  • 11.1.2 Rare Disease Diagnostics Product Offered
  • 11.1.3 Retrophin Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
  • 11.1.4 Main Business Overview
  • 11.1.5 Retrophin News
• 11.2 3billion
  • 11.2.1 Company Details
  • 11.2.2 Rare Disease Diagnostics Product Offered
  • 11.2.3 3billion Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
  • 11.2.4 Main Business Overview
  • 11.2.5 3billion News
• 11.3 23andMe
  • 11.3.1 Company Details
  • 11.3.2 Rare Disease Diagnostics Product Offered
  • 11.3.3 23andMe Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
  • 11.3.4 Main Business Overview
  • 11.3.5 23andMe News
• 11.4 QIAGEN
  • 11.4.1 Company Details
  • 11.4.2 Rare Disease Diagnostics Product Offered
  • 11.4.3 QIAGEN Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
  • 11.4.4 Main Business Overview
  • 11.4.5 QIAGEN News
• 11.5 Illumina
  • 11.5.1 Company Details
  • 11.5.2 Rare Disease Diagnostics Product Offered
  • 11.5.3 Illumina Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
  • 11.5.4 Main Business Overview
  • 11.5.5 Illumina News
• 11.6 PerkinElmer
  • 11.6.1 Company Details
  • 11.6.2 Rare Disease Diagnostics Product Offered
  • 11.6.3 PerkinElmer Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
  • 11.6.4 Main Business Overview
  • 11.6.5 PerkinElmer News
• 11.7 Strand Life Sciences
  • 11.7.1 Company Details
  • 11.7.2 Rare Disease Diagnostics Product Offered
  • 11.7.3 Strand Life Sciences Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2017-2019)
  • 11.7.4 Main Business Overview
  • 11.7.5 Strand Life Sciences News

...

12 Research Findings and Conclusion

Often rare diseases are chronic and life-threatening. Rare diseases can be single gene, multifactorial, chromosomal or non-genetic.

According to this study, over the next five years the Rare Disease Diagnostics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Rare Disease Diagnostics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Rare Disease Diagnostics market by product type, application, key companies and key regions.

This study considers the Rare Disease Diagnostics value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Hematology
Oncology
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital Laboratories
Diagnostic Laboratories
Genetic Testing Laboratories
Cancer Research Laboratories
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Retrophin
3billion
23andMe
QIAGEN
Illumina
PerkinElmer
Strand Life Sciences
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Rare Disease Diagnostics market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Rare Disease Diagnostics market by identifying its various subsegments.
Focuses on the key global Rare Disease Diagnostics players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rare Disease Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Rare Disease Diagnostics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.